At a Polish military school, teenagers in military-style uniforms crowded around a 15-year-old classmate, pushing him to ...
In September 2024, Sanofi entered an exclusive licensing agreement with Orano Med and RadioMedix to globally commercialize ...
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies ...
In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.
Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
The University of Tennessee ranks in the top 30% of colleges and universities nationwide, according to a new study. WalletHub ...
The Chosun Ilbo on MSN
U.S. Health Secretary Kennedy Jr. and Wife Opt for Economy Class
Robert F. Kennedy Jr., the U.S. Ministry of Health and Welfare secretary from a political dynasty, and his wife, actress ...
1d
The Herpes Hope: How a Modified Virus Is Giving New Options to Patients With Untreatable Skin Cancer
A genetically engineered herpes virus may offer a new and effective treatment for advanced melanoma, providing hope for ...
The Food and Drug Administration (FDA) has approved Gazyva ® (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.
AMT-253 is a potential first-in-class MUC18-directed ADC with a proprietary linker-payload design AMT-253 demonstrated a manageable safety profile, consistent with other TOP1-inhibitor based ADCs Pr ...
EMA committee recommends approval of Insmed’s Brinsupri to treat non-cystic fibrosis bronchiectasis: Bridgewater, New Jersey Monday, October 20, 2025, 15:00 Hrs [IST] Insmed Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback